l carnitine hyperammonemia Nonhepatic Hyperammonemia in Inherited Metabolic Diseases
Description
We found no evidence of a clear difference in the ICD (absolute improvement 4.00 meters, 95% CI 9.86 to 17.86
It wasn't just about the numbers on the scale
Despite this growing body of evidence, current risk stratification models do not incorporate neurocardiac parameters
has three complete production lines for the production of personalized and customized packaging
Recently, Chatham et al
The majority of acylcarnitine is excreted in the urine, allowing for the excretion of abnormal metabolites
